REV1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.867600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.816600E-01
Normal-vs-Stage2
3.926200E-01
Normal-vs-Stage3
5.488100E-02
Normal-vs-Stage4
8.988600E-01
Stage1-vs-Stage2
3.523600E-01
Stage1-vs-Stage3
3.964000E-02
Stage1-vs-Stage4
7.501600E-01
Stage2-vs-Stage3
6.918300E-02
Stage2-vs-Stage4
2.261400E-01
Stage3-vs-Stage4
5.036200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.044800E-01
Normal-vs-AfricanAmerican
4.922200E-01
Normal-vs-Asian
2.643800E-01
Caucasian-vs-AfricanAmerican
8.805400E-01
Caucasian-vs-Asian
2.427200E-01
AfricanAmerican-vs-Asian
5.949200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.043000E-01
Normal-vs-Female
3.864000E-01
Male-vs-Female
9.155000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.833800E-01
Normal-vs-Age(41-60Yrs)
6.621800E-01
Normal-vs-Age(61-80Yrs)
3.222800E-01
Normal-vs-Age(81-100Yrs)
1.176610E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.261200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.137400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.159600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.037600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.605600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.403600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.309600E-01
Normal-vs-Daily Drinker
2.060800E-01
Normal-vs-Weekly Drinker
4.550600E-01
Normal-vs-Occasional Drinker
6.007200E-01
Normal-vs-Social Drinker
7.478000E-01
Non Drinker-vs-Daily Drinker
9.389800E-01
Non Drinker-vs-Weekly Drinker
4.960800E-01
Non Drinker-vs-Occasional Drinker
1.325550E-01
Non Drinker-vs-Social Drinker
1.675620E-01
Daily Drinker-vs-Weekly Drinker
5.310200E-01
Daily Drinker-vs-Occasional Drinker
1.449360E-01
Daily Drinker-vs-Social Drinker
1.931000E-01
Weekly Drinker-vs-Occasional Drinker
5.399600E-01
Weekly Drinker-vs-Social Drinker
5.529800E-01
Occasional Drinker-vs-Social Drinker
9.017200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.338170E-01
Normal-vs-Grade 2
1.587890E-02
Normal-vs-Grade 3
1.532070E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.550400E-02
Grade 1-vs-Grade 3
2.981700E-02
Grade 1-vs-Grade 4
1.338170E-01
Grade 2-vs-Grade 3
5.223800E-01
Grade 2-vs-Grade 4
1.587890E-02
Grade 3-vs-Grade 4
1.532070E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.446800E-01
Normal-vs-NonDiabetic
3.508600E-01
Diabetic-vs-NonDiabetic
5.030600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.136000E-01
Normal-vs-NoPancreatitis
2.966800E-01
Pancreatitis-vs-NoPancreatitis
2.767800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.572400E-01
Normal-vs-N1
3.728200E-01
N0-vs-N1
8.661200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.472400E-01
Normal-vs-TP53-NonMutant
5.280200E-01
TP53-Mutant-vs-TP53-NonMutant
7.677200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
